Hugh Young Rienhoff
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Acute Myeloid Leukemia Research, Hemoglobinopathies and Related Disorders, Myeloproliferative Neoplasms: Diagnosis and Treatment, Iron Metabolism and Disorders
Most-Cited Works
- → A public resource facilitating clinical use of genomes(2012)244 cited
- → Dietary iron restriction or iron chelation protects from diabetes and loss of β-cell function in the obese (ob/ob lep−/−) mouse(2010)163 cited
- → RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML(2020)151 cited
- → Cyclic hyperalimentation: An optimal technique for preservation of visceral protein(1976)146 cited
- → LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML(2018)115 cited
- → Inhibition of LSD1 with Bomedemstat Sensitizes Small Cell Lung Cancer to Immune Checkpoint Blockade and T-Cell Killing(2022)110 cited
- → A mutation in TGFB3 associated with a syndrome of low muscle mass, growth retardation, distal arthrogryposis and clinical features overlapping with marfan and loeys–dietz syndrome(2013)106 cited
- → LSD1 Inhibition Prolongs Survival in Mouse Models of MPN by Selectively Targeting the Disease Clone(2018)94 cited
- → The use of appropriate calibration curves corrects for systematic differences in liver R2* values measured using different software packages(2013)80 cited
- → Liver MRI is more precise than liver biopsy for assessing total body iron balance: a comparison of MRI relaxometry with simulated liver biopsy results(2015)63 cited